Description

Xalatan (Latanoprost) Eye Drops 0.005% – 2.5 ml Vial

Composition

Active Ingredient: Latanoprost 0.005%

Other Ingredients: Benzalkonium chloride, sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate anhydrous, water for injection

Mechanism of Action

Latanoprost, a prostaglandin analog, increases the outflow of aqueous humor from the eye, reducing intraocular pressure by enhancing uveoscleral outflow.

Pharmacological Properties

Latanoprost reduces intraocular pressure by facilitating aqueous humor drainage, making it effective in managing conditions like glaucoma and ocular hypertension.

Indications for Use

Xalatan eye drops are indicated for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Contraindications

Avoid Xalatan eye drops if allergic to any ingredients. Consult a healthcare provider before use during pregnancy, planning for pregnancy, or breastfeeding.

Side Effects

Possible side effects include eye irritation, stinging, blurred vision, and changes in eyelash growth. Contact a healthcare provider if experiencing severe side effects.

Usage Instructions

Administer 1 drop in the affected eye(s) once daily in the evening. Avoid more frequent use as it may diminish the intraocular pressure-lowering effect.

Benefits Compared to Analogues

Xalatan’s once-daily dosing regimen offers convenience and compliance advantages over other intraocular pressure-lowering agents, making it a preferred choice for glaucoma management.

Suitable Patient Groups

Xalatan is suitable for adults, including the elderly, but specific dosing adjustments may be necessary based on individual patient factors.

Storage and Shelf Life

Store Xalatan vials in a cool, dry place away from direct sunlight. Check the expiration date and do not use expired medication.

Packaging Description

Xalatan is available in 2.5 ml vials with each vial containing 0.005% Latanoprost solution for ophthalmic use.

Clinical Evidence and Proven Effectiveness

Latanoprost has been extensively studied and proven effective in reducing intraocular pressure and managing glaucoma. Clinical trials have demonstrated its efficacy and tolerability compared to other treatments.